艾迪药业: 艾迪药业监事会关于2025年股票期权激励计划首次授予激励对象名单的审核意见及公示情况说明

Core Viewpoint - The company has approved the initial list of incentive recipients for the 2025 stock option incentive plan, ensuring compliance with relevant regulations and internal governance [1][2][3] Disclosure Situation - The company publicly disclosed the names and positions of the proposed incentive recipients internally from June 27, 2025, to July 7, 2025, for a minimum of 10 days, allowing employees to provide feedback [1] Review Method - The supervisory board verified the proposed recipients' identities, employment contracts, and positions within the company and its subsidiaries [2] Supervisory Board Review Opinion - The supervisory board confirmed that all proposed recipients meet the qualifications set forth by relevant laws and regulations, including not being disqualified by the securities exchange or regulatory authorities in the past 12 months [2][3]